323 results
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
9 May 24
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
7:00am
and health benefits of breastfeeding should be considered along with the mother’s clinical need for Galafold and any potential adverse effects
8-K
EX-99.1
7cweu
28 Feb 24
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
7:02am
8-K
EX-99.1
dj1qer2u 8d5fp
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
S-3ASR
oei9tjz3dk89qv0mqt
8 Nov 23
Automatic shelf registration
5:25pm
8-K
EX-99.1
d94j4dhy 3fm9o0nj6pq
8 Nov 23
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
r6j1qf
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-10.2
5olfh luk87zteg
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-99.1
a76 s2fxf
27 Sep 23
AT THE FOREFRONT OF THERAPIES FOR RARE DISEASES Corporate Overview September 2023
7:00am
8-K
EX-99.1
27vzo81h
15 Aug 23
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
7:00am
8-K
EX-99.1
ctt2nw8gq6glrazuf58
8 Aug 23
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
rawv uq5sryxph24qm9e
13 Jul 23
Departure of Directors or Certain Officers
5:00pm